Filter
642
Text search:
Mild
COVID
Featured
Recommendations
112
New Publications
4
Language
Document type
Guidelines
250
Studies & Reports
134
Fact sheets
87
Manuals
57
Strategic & Response Plan
42
Situation Updates
23
Training Material
15
Infographics
10
Brochures
7
Resource Platforms
6
Videos
4
No document type
4
Online Courses
3
Countries / Regions
Global
34
India
29
South Africa
25
Germany
24
Syria
22
Western and Central Europe
22
Latin America and the Carribbean
21
Middle East and North Africa
18
Russia
18
Brazil
17
East and Southern Africa
15
West and Central Africa
15
Africa
15
Eastern Europe and Central Asia
14
Kenya
11
South–East Asia Region
10
South Sudan
9
Yemen
9
Bangladesh
7
Mozambique
6
Nigeria
5
Congo, Democratic Republic of
5
Angola
5
Western Pacific Region
5
Vietnam
5
Ethiopia
4
Jordan
4
Eastern Europe
4
United Kingdom
4
Guinea-Bissau
3
Ghana
3
Philippines
3
Lebanon
3
China
3
Malawi
3
Ukraine
3
Chile
3
Paraguay
3
Palestine
3
Tajikistan
3
Burkina Faso
2
Sierra Leone
2
Côte d’Ivoire / Ivory Coast
2
Zimbabwe
2
Nepal
2
Pakistan
2
Iraq
2
Afghanistan
2
Turkey
2
Cambodia
2
Colombia
2
Ecuador
2
Laos
2
Kazakhstan
2
Portugal
2
Liberia
1
Mali
1
Saudi Arabia
1
Uganda
1
Somalia
1
Egypt
1
Chad
1
Tanzania
1
Thailand
1
Rwanda
1
Singapore
1
Sudan
1
Benin
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Austria
1
Switzerland
1
Serbia
1
Bolivia
1
Myanmar / Burma
1
Sri Lanka
1
Asia
1
Fiji
1
Venezuela
1
Armenia
1
Congo-Brazzaville
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Georgia
1
North America
1
France
1
Spain
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
275
Clinical Guidelines
36
Public Health
26
Women & Child Health
22
Key Resources
16
Capacity Building
8
Pharmacy & Technologies
6
Toolboxes
COVID-19
457
NCDs
20
NTDs
13
Refugee
11
Malaria
11
Conflict
10
Planetary Health
10
Mental Health
9
Rapid Response
8
TB
8
Caregiver
8
HIV
7
Pharmacy
7
2.0 Rapid Response
7
AMR
6
Disability
5
Health Financing Toolbox
4
Natural Hazards
3
Cholera
2
Ebola & Marburg
1
Zika
1
Global Health Education
1
Updated 28 December 2020
Why are experts concerned about COVID-19 and antibiotics? And what can you do about it? Learn about antibiotics and COVID-19 from WHO’s Dr Hanan Balkhy in Science in 5
Bei vielen schwer erkrankten Menschen muss mit einer im Verhältnis zu anderen schweren ARE längeren Behandlung mit Beatmung/zusätzlichem Saürstoffbedarf gerechnet werden. Da weder eine Impfung noch eine spezifische Therapie derzeit zur Verfügung stehen, müssen alle Massnahmen darauf ausgericht
...
Several countries have demonstrated that COVID-19 transmission from one person to another can be slowed or stopped. This document has been prepared based on the evidence currently available about Coronavirus disease 2019 (
...
Accessed: 02.05.2020
Coronaviruses are a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest v
...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I
...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC
...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов
...
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
Natural immunity against COVID-19
Scientific report 10 May 2021
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses,
...
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
This assessment tool is to support municipalities and local authorities in identifying the risks and vulnerabilities that refugees and migrants face and to identify gaps where possible methods to minimize the impact of the pandemic exist so that they can be prioritized within local policy processes.
...
Scientific Brief, 17 June 2020
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the peri
...
